GR1001195B - Διαδικασια για την παρασκευη μιας φαρμακευτικης συνθεσης για τηνθεραπεια αυτοανοσων νοσηματων. - Google Patents

Διαδικασια για την παρασκευη μιας φαρμακευτικης συνθεσης για τηνθεραπεια αυτοανοσων νοσηματων.

Info

Publication number
GR1001195B
GR1001195B GR900100406A GR900100406A GR1001195B GR 1001195 B GR1001195 B GR 1001195B GR 900100406 A GR900100406 A GR 900100406A GR 900100406 A GR900100406 A GR 900100406A GR 1001195 B GR1001195 B GR 1001195B
Authority
GR
Greece
Prior art keywords
pct
preparation process
treatment composition
carbon atoms
pharmaceutical treatment
Prior art date
Application number
GR900100406A
Other languages
English (en)
Other versions
GR900100406A (en
Inventor
Manuel Dr Modolell
Gerhard Dr Prof Munder
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of GR900100406A publication Critical patent/GR900100406A/el
Publication of GR1001195B publication Critical patent/GR1001195B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση προμηθεύει μία διαδικασία για την παρασκευή μιας φαρμακευτικής σύνθεσης για την θεραπεία αυτοανόσων νοσημάτων, με εξαίρεση την σκλήρυνση κατά πλάκας, όπου χρησιμοποιούνται προϊόντα του γενικού τύπου: ω
GR900100406A 1989-06-02 1990-05-29 Διαδικασια για την παρασκευη μιας φαρμακευτικης συνθεσης για τηνθεραπεια αυτοανοσων νοσηματων. GR1001195B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918082A DE3918082A1 (de) 1989-06-02 1989-06-02 Mittel gegen autoimmunerkrankungen

Publications (2)

Publication Number Publication Date
GR900100406A GR900100406A (en) 1991-11-15
GR1001195B true GR1001195B (el) 1993-06-07

Family

ID=6381972

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100406A GR1001195B (el) 1989-06-02 1990-05-29 Διαδικασια για την παρασκευη μιας φαρμακευτικης συνθεσης για τηνθεραπεια αυτοανοσων νοσηματων.

Country Status (14)

Country Link
US (1) US5266564A (el)
EP (1) EP0474712B1 (el)
JP (1) JP2977894B2 (el)
AT (1) ATE94757T1 (el)
AU (1) AU5670690A (el)
CA (1) CA2056421C (el)
CS (1) CS276439B6 (el)
DE (2) DE3918082A1 (el)
DK (1) DK0474712T3 (el)
ES (1) ES2060173T3 (el)
GR (1) GR1001195B (el)
IE (1) IE64039B1 (el)
WO (1) WO1990014829A1 (el)
ZA (1) ZA904196B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941009A1 (de) * 1989-12-12 1991-06-13 Medmark Pharma Gmbh Eliminierung von aktivierten lymphozyten
MX336813B (es) * 1996-02-09 2016-02-02 Abbvie Biotechnology Ltd Anticuerpos humanos que ligan el tnfa humano.
US6583127B1 (en) 1998-12-21 2003-06-24 Inkeysa. Sa Use of etherlysophospholipids as antiinflammatory agents
SE9902155L (sv) * 1999-06-09 2000-12-10 Bjoern Rydevik Serum antibodies
JP2002228764A (ja) * 2001-02-02 2002-08-14 Fuji Photo Film Co Ltd 透光性シート体検出装置
CN101610758A (zh) * 2006-11-10 2009-12-23 阿尔法普托斯有限公司 含有三取代甘油化合物的口服剂型
US20100130449A1 (en) * 2006-11-10 2010-05-27 Alphaptose Gmbh Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
CN101606061B (zh) 2006-11-10 2014-01-22 阿尔法普托斯有限公司 用于检测受体配体模拟物的方法和组合物
WO2008074573A1 (en) * 2006-12-20 2008-06-26 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
DK2144618T3 (da) 2007-03-28 2013-06-17 Aker Biomarine As Bioeffektive krill-olie-sammensætninger
CN101827529B (zh) * 2007-08-29 2014-01-15 阿克海洋生物股份公司 制备磷虾粉的方法
US20100226977A1 (en) * 2007-08-29 2010-09-09 Aker Biomarine Asa Low viscosity phospholipid compositions
US8372812B2 (en) * 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
US10456412B2 (en) 2015-02-11 2019-10-29 Aker Biomarine Antarctic As Lipid extraction processes
KR102515207B1 (ko) 2015-02-11 2023-03-29 에이커 바이오마린 앤탁틱 에이에스 지질 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
DE2009342C3 (de) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
CH670763A5 (el) * 1985-08-02 1989-07-14 Seuref Ag
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose

Also Published As

Publication number Publication date
GR900100406A (en) 1991-11-15
EP0474712B1 (de) 1993-09-22
ES2060173T3 (es) 1994-11-16
IE901987L (en) 1990-12-02
DE3918082A1 (de) 1991-01-24
IE64039B1 (en) 1995-06-28
ZA904196B (en) 1991-03-27
CS276439B6 (en) 1992-05-13
DK0474712T3 (da) 1993-11-29
ATE94757T1 (de) 1993-10-15
JP2977894B2 (ja) 1999-11-15
AU5670690A (en) 1991-01-07
US5266564A (en) 1993-11-30
JPH04507096A (ja) 1992-12-10
DE59002863D1 (de) 1993-10-28
EP0474712A1 (de) 1992-03-18
CA2056421A1 (en) 1990-12-03
CA2056421C (en) 2000-10-10
WO1990014829A1 (de) 1990-12-13
DE3918082C2 (el) 1992-02-06
CS268990A3 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
ZA904196B (en) Process for the preparation of a pharmaceutical composition for the treatment of autoimmune diseases
HU896769D0 (en) Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients
ZA858456B (en) Polypeptide
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
IL82084A0 (en) 1,4-diazepines,their preparation and pharmaceutical compositions containing them
ES8105997A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
HUT37767A (en) Process for preparing isoxazole derivatives further pharmaceutical compositions containing such compounds as active substances
AU601177B2 (en) Thiodiazolylurea-containing agent for defoliating plants
LTIP1733A (en) Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation
DE2962856D1 (en) Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
DE69017146D1 (de) Verfahren zur Herstellung von 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbonsäurethioamid-1-(1R,2R)oxyden, die so erhaltenen 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbothioamid-1-(1R,2R)oxyde und diese enthaltende pharmazeutische Zusammenstellungen.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees